Skip to main content
Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: IGF-1C domain-modified hydrogel enhances therapeutic potential of mesenchymal stem cells for hindlimb ischemia

Fig. 5

CS-IGF-1C hydrogel co-transplanted with hP-MSCs enhanced blood perfusion of the injured hindlimb. a Photograph of angiography on day 21 showed the collateral vessels in the ischemic hindlimb. All mice models were in prone position for photos. b Angiography score indicated that treated with hP-MSCs and CS-IGF-1C hydrogel significantly augmented the collateral vessels. Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01 versus sham; ##P < 0.01 versus PBS; $$P < 0.01 versus hP-MSCs; &&P < 0.01 versus hP-MSCs + CS. c Percentage distributions of limb salvage, foot necrosis, and limb loss in each group on day 14

Back to article page